Current Trials

Currently available Clinical Trials for melanoma at the North Bay Melanoma Program as of November 2008:

For early stage 1-2 melanoma (skin deep)

“A phase II study of high resolution contrast-enhanced MRI of regional lymph nodes in patients with clinically localized invasive melanoma.”

This trial assesses the accuracy of MRI compared to results obtained at lymph node biopsy, and has been designed by North Bay Melanoma Program physicians Dr. Peter Brett and Dr. David Feinberg, and approved by the Santa Rosa Memorial Hospital Institutional Review Board. For more information on this clinical trial, please visit the U.S. National Institutes of Health website for nationally registered clinical trials.

For stage 3 melanoma (involving lymph nodes)

"GSK 2132231A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patinets With Resected Melanoma.” This is an international study sponsored by GlaxoSmithKline.

For stage 4 melanoma (that has spread beyond adjacent lymph nodes)

“Efficacy and Safety Study of OncoVEX-GM-CSF Compared to GM-CSF in Melanoma.” This is an international study sponsored by BioVex.